InvestorsHub Logo
Followers 83
Posts 37853
Boards Moderated 1
Alias Born 05/09/2017

Re: None

Thursday, 06/08/2017 12:05:54 AM

Thursday, June 08, 2017 12:05:54 AM

Post# of 107737
MYDX, why I believe MYDX is currently involved in China market:
Occam's Razor approach to explain why I believe MYDX is still involved in China market with roi to follow:

In minute 16 of this video(link to follow), Yazbeck mentions how China would be behind 3 years from MYDX market entry(first mover advantage). That would mean that Yazbeck and company knew then that in order to maximize as soon as possible sales in China to offset potential future opportunity loss/deceleration of sales. So what better way to accomplish this than to make a deal with China for 5 years(2 bonus years) to license the product for distribution/marketing of entire MYDX line. Currently, there are only 3 of the 6 being marketed because AquaDX, OrganaDX, and AeroDX's analyzer haven't hit the market yet. The only 3 products being sold are the MYDX unit with CannaDX analyzer, AquaDX single use sensor which doesn't have the value of data analysis, and OrganaDX single use sensor which doesn't have the value of data analysis. It stands to reason, since it is a 5 year deal, that MYDX intended all along to have all analyzers ready for market before the 5 years ended, and most likely within the first 2 years to maintain 3 year advantage of new analyzers under the 5 year term. It stands to reason that once all the intended products hit the China market, MYDX will be making headline global news. These are first mover products, not just early mover. Most people who hadn't even heard the name MYDX are most likely going to be blown away by its ability.

Here is the link to Yazbeck's speech where he mentions 3 years ahead of China:


Here is link about the 5 year China licensing:
http://ir.cdxlife.com/press-releases/detail/45/mydx-reports-strong-third-quarter-2016-financial-results
"During the third quarter, while completing the development, branding and launch of the AquaDx and OrganaDx product lines, we have been working diligently to create, negotiate and close a landmark Asian licensing distribution deal,” he added. “We are pleased to report successfully closing a 5 year $2.5 million high-margin transaction with our first licensing partner in China who will market and distribute the OrganaDx, AquaDx, and AeroDx product lines in that region.”

Occam's Razor link:
https://en.m.wikipedia.org/wiki/Occam%27s_razor

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.